In DCE-MRI, the effect of the r2* relaxivity of gadolinium-based contrast agents is often assumed to be negligible. Here, the validity of this assumption at 7T was tested. DCE-MRI was performed on two preclinical cancer models using a spoiled multiple gradient-echo acquisition, which enabled correction for transverse relaxation. Not accounting for R2* resulted in underestimation of the Tofts pharmacokinetic parameters, with Ktrans being the most affected and vp the least. Simulations showed that the R2* effect can be significant even at 3T in highly perfused regions but can be mitigated by decreasing TE and TR or increasing the flip angle.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords